Liverpool Chirochem (LCC) is a chemistry-based contract research organisation for biotechnology and pharmaceutical research and development. It produces chiral small molecules that can be used as building blocks to support drug discovery.
As a business rich in intellectual property, with almost unrivalled PhD talent, LCC showed potential for early-stage investment. We backed an experienced management team with a clear goal of bringing cutting-edge research to market.
Liverpool Chirochem is also a member of the Royal Society of Chemistry’s EnterprisePlus program, with offices in Liverpool and China.
“The management team at LCC were keen to work with Praetura because we were extremely impressed by the business acumen of Praetura’s leadership, who clearly also believe in the business case and potential for the company to succeed.”
Paul Colbon, CEO